Intellia Therapeutics Aktie

7,69 EUR -0,44 EUR -5,37 %

09:19:15

FSE

8,74 USD -0,58 USD -6,17 %

25.03.2025

BTT

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

Marktkap.893,10 Mio. EUR

Div. Rendite0,00%

WKNA2AG6H

ISINUS45826J1051

SymbolNTLA

Intellia Therapeutics Aktien News

Sortieren:Datum Meistgelesen

25.03.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Intellia Therapeutics, Inc of Class Action Lawsuit and Upcoming Deadlines - NTLA

25.03.25PR NewswireNTLA Investors are reminded of Opportunity to Lead Intellia Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

20.03.25PR NewswireNTLA Investors Have Opportunity to Lead Intellia Therapeutics, Inc. Securities Fraud Lawsuit

WerbungIntellia Therapeutics-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero

17.03.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Intellia Therapeutics, Inc of Class Action Lawsuit and Upcoming Deadlines - NTLA

04.03.25PR NewswireLevi & Korsinsky Reminds Intellia Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 14, 2025 - NTLA

03.03.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Intellia Therapeutics, Inc of Class Action Lawsuit and Upcoming Deadlines - NTLA

03.03.25PR NewswireNTLA Investors Have Opportunity to Lead Intellia Therapeutics, Inc. Securities Fraud Lawsuit

28.02.25BenzingaWhat Analysts Are Saying About Intellia Therapeutics Stock

28.02.25PR NewswireApril 14, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against NTLA

27.02.25MotleyFoolIntellia Therapeutics Delivers a Q4 Beat

27.02.25ZacksIntellia Therapeutics, Inc. (NTLA) Reports Q4 Loss, Tops Revenue Estimates

26.02.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Intellia Therapeutics, Inc of Class Action Lawsuit and Upcoming Deadlines - NTLA

24.02.25PR NewswireNTLA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Intellia Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

20.02.25ZacksIntellia Therapeutics, Inc. (NTLA) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

20.02.25ZacksIntellia Therapeutics (NTLA) Stock Jumps 6.5%: Will It Continue to Soar?

18.02.25PR NewswireIntellia Therapeutics, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before April 14, 2025 to Discuss Your Rights - NTLA

16.02.25PR NewswireNTLA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Intellia Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

14.02.25ZacksDoes Intellia Therapeutics (NTLA) Have the Potential to Rally 422.41% as Wall Street Analysts Expect?

14.02.25PR NewswireLevi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Intellia Therapeutics, Inc.(NTLA) Shareholders

28.01.25PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Intellia Therapeutics, Inc - NTLA

13.01.25Benzinga13 Analysts Have This To Say About Intellia Therapeutics

11.01.25BenzingaCathie Wood's Ark Invest Loads Up On Intellia Therapeutics Which Laid Off Over A Quarter Of Its Workforce

10.01.25BenzingaWhy Is Intellia Therapeutics Stock Trading Lower On Friday?

22.11.24MotleyFoolDown 33% in 1 Month, Should You Buy the Dip With Intellia Therapeutics Stock?

11.11.24Benzinga9 Analysts Have This To Say About Intellia Therapeutics

07.11.24ZacksIntellia Therapeutics, Inc. (NTLA) Reports Q3 Loss, Tops Revenue Estimates

06.11.24MotleyFoolIntellia Therapeutics Just Notched Another Win. So Why Did Its Stock Fall 18% in 1 Day?

25.10.24Benzinga7 Analysts Have This To Say About Intellia Therapeutics

25.10.24BenzingaMonopar Therapeutics, Intellia Therapeutics, Capri Holdings, Western Digital, And Tesla: Why These 5 Stocks Are On Investors' Radars Today

25.10.24MotleyFoolWhy Intellia Therapeutics Stock Plummeted by 20% Today

24.10.24BenzingaWhy Is Gene Therapy-Focused Intellia Therapeutics Stock Trading Lower On Thursday?

17.10.24ZacksIntellia Therapeutics, Inc. (NTLA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

11.09.24BenzingaExpert Outlook: Intellia Therapeutics Through The Eyes Of 7 Analysts

12.08.24BenzingaExpert Ratings For Intellia Therapeutics

08.08.24ZacksIntellia Therapeutics, Inc. (NTLA) Reports Q2 Loss, Lags Revenue Estimates

11.07.24ZacksAll You Need to Know About Intellia Therapeutics (NTLA) Rating Upgrade to Strong Buy

09.07.24MotleyFoolThe Bull Case for Intellia Therapeutics Stock Just Got Even Stronger

24.06.24BenzingaUnveiling 6 Analyst Insights On Intellia Therapeutics

08.06.24MotleyFoolThese 2 Words Are Why Intellia Therapeutics Could Be a Smart Buy Right Now

04.06.24BenzingaCracking The Code: Understanding Analyst Reviews For Intellia Therapeutics

Intellia Therapeutics News

Intellia Therapeutics News: auf dieser Seite finden Sie alle Intellia Therapeutics News und Nachrichten zur Intellia Therapeutics Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Intellia Therapeutics News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Intellia Therapeutics News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.